Arcutis Biotherapeutics, Inc. — SCHEDULE 13G/A Filings
7 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Arcutis Biotherapeutics, Inc. (ARQT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Arcutis Biotherapeutics, Inc. has filed 7 SCHEDULE 13G/A documents with the SEC since 2019. To view all SEC filings by Arcutis Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000405 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015201 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0000053417-26-000007 | Jan 30, 2026 | — |
| SCHEDULE 13G/A | — | 0000053417-25-000086 | Oct 6, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-003250 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002030 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000053417-25-000052 | May 8, 2025 | — |